Li Gui-Hua, Post Jennifer, Koibuchi Noriyuki, Sajdel-Sulkowska Elizabeth M
Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Cerebellum. 2004;3(2):100-6. doi: 10.1080/14734220410029650.
The developing rat cerebellum is vulnerable to thyroid hormone (TH) deficiency. The present study addresses the molecular mechanisms involved in this response. Specifically, the study focuses on the expression of selected cerebellar proteins that are known to be directly [protein expressing 3-fucosyl-N-acetyl-lactosamine antigen (CD15), neuronal cell adhesion molecule (L1)] or indirectly [glial fibrillary acidic protein (GFAP)], involved in glial-neuronal interactions and thus regulation of cell proliferation and granule cell migration. Cerebellar mass, structure, and protein expression in rat neonates exposed to antithyroid drug propylthiouracil (PTU) from the embryonic day (E) 16 to postnatal day (P) 21 were compared against rat neonates that received replacement of thyroxin (T4) starting on day P1 or untreated controls. Cerebellar proteins were analyzed by quantitative Western blots. PTU-treated rats lagged in growth and showed reduction in cerebellar mass and alterations in cerebellar structure on P15. Daily treatment of neonates with T4 restored normal cerebellum-to-body-mass ratio, cerebellar structure, and cerebellar protein expression. Densitometric analysis of Western blots revealed altered expression of selected proteins in the cerebella of hypothyroid neonates. A decrease of CD15 (46%, p = 0.031) was observed on P10 and was accompanied by a decrease in GFAP expression (64%, p = 0.039). Furthermore, a shift in the developmental GFAP profile was observed in the PTU-treated cerebellum. L1 expression was not significantly affected in the hypothyroid cerebellum. Altered expression of cerebellar proteins is likely to affect cell-cell interactions and consequently cell proliferation and migration and contribute to structural and functional alterations seen in the hypothyroid rat neonates.
发育中的大鼠小脑易受甲状腺激素(TH)缺乏的影响。本研究探讨了参与这种反应的分子机制。具体而言,该研究聚焦于某些已知直接[表达3-岩藻糖基-N-乙酰乳糖胺抗原的蛋白质(CD15)、神经元细胞粘附分子(L1)]或间接[胶质纤维酸性蛋白(GFAP)]参与神经胶质-神经元相互作用从而调节细胞增殖和颗粒细胞迁移的小脑蛋白质的表达。将从胚胎第16天(E)至出生后第21天(P)暴露于抗甲状腺药物丙硫氧嘧啶(PTU)的新生大鼠的小脑质量、结构和蛋白质表达,与从出生后第1天(P1)开始接受甲状腺素(T4)替代治疗的新生大鼠或未治疗的对照组进行比较。通过定量蛋白质免疫印迹法分析小脑蛋白质。PTU处理的大鼠生长滞后,在出生后第15天显示小脑质量减少和小脑结构改变。每天用T4治疗新生大鼠可恢复正常的小脑与体重比、小脑结构和小脑蛋白质表达。蛋白质免疫印迹的光密度分析显示甲状腺功能减退新生大鼠小脑中所选蛋白质的表达发生改变。在出生后第10天观察到CD15减少(46%,p = 0.031),同时GFAP表达也减少(64%,p = 0.039)。此外,在PTU处理的小脑中观察到GFAP发育谱的变化。L1表达在甲状腺功能减退的小脑中未受到显著影响。小脑蛋白质表达的改变可能会影响细胞间相互作用,进而影响细胞增殖和迁移,并导致甲状腺功能减退新生大鼠出现结构和功能改变。